Xeris Pharmaceuticals | XERS - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -921K 40.8M 2026-03
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 85.83M 23.34M 2026-03
Sartorius EUR 127M 30.8M 2026-06
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03